Literature DB >> 7694229

Interaction of the C-terminal region of p105 with the nuclear localisation signal of p50 is required for inhibition of NF-kappa B DNA binding activity.

J R Matthews1, E Watson, S Buckley, R T Hay.   

Abstract

DNA binding of the homodimeric p50 subunit of NF-kappa B was inhibited by a bacterially expressed protein containing the ankyrin repeats present in the C-terminus of the p105 precursor but not by the I kappa B protein MAD-3. However p50 was retained on protein affinity matrices containing either the C-terminal ankyrin repeats of p105 or MAD-3. To investigate the interaction between p50 and proteins containing ankyrin repeats we have used a number of approaches to probe the accessibility of the p50 nuclear localisation signal in the protein complex. A monoclonal antibody recognising a linear epitope either very close to, or including, the nuclear localisation signal of the p50 protein could immunoprecipitate p50 homodimers but was unable to precipitate the protein when it was bound to the C-terminal region of p105. A close association between the nuclear localisation signal of p50 and the C-terminal region of p105 was also suggested by protease accessibility experiments. While the nuclear localisation signal of free p50 is extremely susceptible to cleavage with trypsin the same site is masked in the presence of the C-terminal ankyrin repeats of p105 and, to a lesser extent MAD-3. Removal of the nuclear localisation signal by trypsin digestion generates a protein that is fully competent for DNA binding but is refractile to inhibition by the C-terminal ankyrin repeats of p105. Addition of DNA destabilises complexes between p50 and ankyrin repeat containing proteins, increasing the susceptibility of the nuclear localisation signal to trypsin cleavage. The data suggest that there is a rapid exchange of p50 between complexes containing DNA or I kappa B proteins via a metastable complex containing DNA, p50 and I kappa B.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694229      PMCID: PMC311184          DOI: 10.1093/nar/21.19.4516

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  41 in total

1.  A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon.

Authors:  E Brownell; N Mittereder; N R Rice
Journal:  Oncogene       Date:  1989-07       Impact factor: 9.867

2.  Similarity between cell-cycle genes of budding yeast and fission yeast and the Notch gene of Drosophila.

Authors:  L Breeden; K Nasmyth
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

3.  Purified human I kappa B can rapidly dissociate the complex of the NF-kappa B transcription factor with its cognate DNA.

Authors:  U Zabel; P A Baeuerle
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

4.  Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins.

Authors:  S E Lux; K M John; V Bennett
Journal:  Nature       Date:  1990-03-01       Impact factor: 49.962

5.  Phorbol-ester-induced activation of the NF-kappa B transcription factor involves dissociation of an apparently cytoplasmic NF-kappa B/inhibitor complex.

Authors:  P A Baeuerle; M Lenardo; J W Pierce; D Baltimore
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1988

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Dorsal, an embryonic polarity gene in Drosophila, is homologous to the vertebrate proto-oncogene, c-rel.

Authors:  R Steward
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

8.  Nucleic acid sequences of the oncogene v-rel in reticuloendotheliosis virus strain T and its cellular homolog, the proto-oncogene c-rel.

Authors:  K C Wilhelmsen; K Eggleton; H M Temin
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

9.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

10.  Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

View more
  15 in total

1.  Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli.

Authors:  G Courtois; S T Whiteside; C H Sibley; A Israel
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

2.  IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice.

Authors:  J F Klement; N R Rice; B D Car; S J Abbondanzo; G D Powers; P H Bhatt; C H Chen; C A Rosen; C L Stewart
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

3.  I(kappa)B(gamma) inhibits DNA binding of NF-kappaB p50 homodimers by interacting with residues that contact DNA.

Authors:  S Bell; J R Matthews; E Jaffray; R T Hay
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

4.  Specificity of Rel-inhibitor interactions in Drosophila embryos.

Authors:  K Tatei; M Levine
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

5.  Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B.

Authors:  F Arenzana-Seisdedos; J Thompson; M S Rodriguez; F Bachelerie; D Thomas; R T Hay
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

6.  Inducible degradation of I kappa B alpha in vitro and in vivo requires the acidic C-terminal domain of the protein.

Authors:  M S Rodriguez; I Michalopoulos; F Arenzana-Seisdedos; R T Hay
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

7.  The PEST-like sequence of I kappa B alpha is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers.

Authors:  M K Ernst; L L Dunn; N R Rice
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

8.  A cell-penetrating peptide suppresses inflammation by inhibiting NF-κB signaling.

Authors:  Yu Fu Wang; Xiang Xu; Xia Fan; Chun Zhang; Qiang Wei; Xi Wang; Wei Guo; Wei Xing; Jian Yu; Jing-Long Yan; Hua-Ping Liang
Journal:  Mol Ther       Date:  2011-05-10       Impact factor: 11.454

9.  Ribozyme-mediated targeting of IkappaBgamma inhibits melanoma invasion and metastasis.

Authors:  Sima Z Torabian; David de Semir; Mehdi Nosrati; Sepideh Bagheri; Altaf A Dar; Sylvia Fong; Yong Liu; Scot Federman; Jeff Simko; Chris Haqq; Robert J Debs; Mohammed Kashani-Sabet
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

10.  Domain organization of I kappa B alpha and sites of interaction with NF-kappa B p65.

Authors:  E Jaffray; K M Wood; R T Hay
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.